Editorial Policy and Medical Review
HealthRX publishes medical content for patients and clinicians making decisions about GLP-1 medications, hormone therapy, peptide medicine, labs, safety, access, and treatment logistics. Our standard is simple: claims must be clear enough for a patient, specific enough for a clinician, and traceable enough for an auditor.
Clinical Review
Every medical article is reviewed by the HealthRX Medical Team before publication. Review checks include indication accuracy, contraindications, dosing language, risk framing, citation quality, and whether the article distinguishes approved uses from off-label or investigational use.
Sources
We prioritize FDA labels, PubMed-indexed clinical trials, major society guidelines, prescribing information, clinical trial registries, and government or academic sources. Commercial sources may be used for pricing or access context, but not as the basis for medical claims.
Freshness
Each article displays a last-reviewed date. Content is re-reviewed when major labels, guidelines, safety communications, or pivotal trials change the clinical interpretation. High-risk medication and safety pages are prioritized for faster review.
Conflicts and Commercial Separation
Editorial content is educational. It does not guarantee prescription approval, medical eligibility, insurance coverage, or dispensing. Commercial product pages and editorial medical articles are treated as separate surfaces with different review expectations.
Corrections
If an error is identified, HealthRX corrects the page, updates the modified date when the correction is material, and prioritizes safety-related corrections first. Readers can report issues at support@healthrx.com.